Henry Schein Q2 2022 Earnings Report
Key Takeaways
Henry Schein reported a 2.1% increase in net sales, reaching $3.0 billion. GAAP diluted EPS increased to $1.16, compared to $1.10 in the second quarter of 2021. The company reaffirmed its full-year 2022 GAAP diluted EPS guidance range of $4.75 to $4.91.
Second-quarter net sales reached $3.0 billion, a 2.1% increase compared to Q2 2021.
Internal sales grew by 6.7% in local currencies, excluding PPE and COVID-19 related products.
GAAP diluted EPS was $1.16, compared to $1.10 in Q2 2021.
The company reaffirmed its full-year 2022 GAAP diluted EPS guidance range of $4.75 to $4.91.
Henry Schein
Henry Schein
Henry Schein Revenue by Segment
Henry Schein Revenue by Geographic Location
Forward Guidance
Henry Schein affirmed its full-year 2022 GAAP diluted EPS guidance range of $4.75 to $4.91 and updated full-year 2022 expected sales growth to be approximately 3% to 6% over 2021.
Positive Outlook
- Affirms guidance for full-year 2022 GAAP diluted EPS attributable to Henry Schein, Inc. of $4.75 to $4.91.
- Reflects growth of 7% to 10% compared with 2021 GAAP diluted EPS of $4.45
- Reflects growth of 5% to 9% compared with 2021 non-GAAP diluted EPS of $4.52.
- Assumes that foreign currency exchange rates will remain generally consistent with current levels
- Assumes that end markets will remain stable and consistent with current market conditions
Challenges Ahead
- Updates full-year 2022 expected sales growth to be approximately 3% to 6% over 2021.
- Reflects adverse effects from foreign exchange rates
- Reflects a decrease in anticipated sales of PPE and COVID-related products, including COVID-19 test kits.
- Sales of COVID-19 test kits are now expected to decline 25% to 30% from 2021
- Assumes that there are no material adverse market changes associated with COVID-19.
Revenue & Expenses
Visualization of income flow from segment revenue to net income